Hong Kong-listed innovative drug stocks rallied after choppy trading: Zai Lab
(09688.HK) rose over 13%, WuXi AppTec (02359.HK) and WuXi Biologics (02269.HK)
gained over 3%, and Rongchang Biologics (09995.HK) and WuXi Helian (02268.HK)
climbed more than 2%.